Global Antimicrobial Resistance Research and Development Hub
Budget
€1,270,776
EP Access
0
accredited persons
Staff
3
0.3 FTE
EU Grants
None
Mission & Goals
The Global AMR R&D Hub was launched in May 2018, following a call from G20 Leaders, to address challenges and improve coordination and collaboration in global AMR R&D using a One Health approach. The Global AMR R&D Hub supports global priority setting and evidence-based decision-making on allocation of resources for AMR R&D through the identification of gaps, overlaps and potential for cross-sectoral collaboration. It is a global partnership currently consisting of 19 countries, the European Commission (EC) and two philanthropic foundations - the Gates Foundation and the Wellcome Trust. Our work is steered by a Board of Members, in consultation with a Stakeholder Group, and supported by a Secretariat based in Berlin. The Hub's key activities include continual development of its Dynamic Dashboard, a key information platform for AMR R&D funding across the One Health spectrum, as well as AMR advocacy and communication efforts at the highest political levels.
EU Legislative Interests
The Global AMR R&D Hub targets the following EU legislative proposals and policies: 1. A European One Health Action Plan against Antimicrobial Resistance (AMR): https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX%3A52017DC0339&qid=1678797696775; https://oeil.secure.europarl.europa.eu/oeil/popups/ficheprocedure.do?reference=2017/2254(INI)&l=en 2. Pharmaceutical Strategy for Europe: https://eur-lex.europa.eu/legal-content/EN/TXT/?uri=CELEX:52020DC0761; https://oeil.secure.europarl.europa.eu/oeil/popups/ficheprocedure.do?reference=2021/2013(INI)&l=en: Commission roadmaps and public consultations: Contribution to the 'Request for support to PwC for a study on medical countermeasures relevant to combat antimicrobial resistance', including the 'Questionnaire for Product Development Partnerships' Contribution to the Online Consultation: Research and Innovation Objectives for the OH AMR Partnership: https://www.jpiamr.eu/open-consultation-oh-amr-research-and-innovation-objectives/
Communication Activities
Communication activities to raise awareness of AMR and the challenges faced is a major component of the Global AMR R&D Hub's work. Although our communication activities do not focus solely on the legislative proposals/policies indicated above, the Hub's work encompasses the broader themes and issues covered in these policies, including research and development of products for addressing AMR and the optimisation of market incentives to encourage their sustainable market entry of and equitable access to these necessary new priority products. Examples activities include: Events: • Participation in multiple events on AMR R&D and pull incentives as part of the French Presidency of the Council of the European Union, March & June 2022; Participation in G20 Health Working Group meetings 2023, 2024 & 2025, participation in the G7 Health Working Group session on AMR in 2025 Networks: • Founding member of the German Network Against AMR (DNAMR) - https://dnamr.de/ Publications - see https://globalamrhub.org/publications/: 1. Incentivising the development of new antibacterial treatments: Progress report by the Global AMR R&D Hub and WHO 2022 & 2023 2. National Health System Tools to improve valuation 3. Market potential and priority patient needs 4. Policy Makers Perspectives on Incentives 5. Public Investments in AMR R&D for animal health vaccines 6. Dynamic Dashboard Annual Report 2020 & 2021 Other activities: 1. AMR Snapshots: The Global AMR Hub's Interview series, which explores key challenges we are facing in AMR, exploring the topic from a variety of different perspectives and featuring key leaders in the field. https://globalamrhub.org/news/?filter=amr-snapshots
Interests Represented
Does not represent commercial interests
Member Of
German Network against Antimicrobial Resistance - https://dnamr.de/
Organisation Members
The Global AMR R&D Hub is a partnership of countries, non-governmental donor organisations and intergovernmental organisations to address challenges and improve coordination and collaboration in global AMR R&D using a One Health approach. It's Board Members include 19 countries (see list below), the European Commission (EC) and two philanthropic foundations - the Gates Foundation and the Wellcome Trust. WHO, FAO, WOAH, OECD and Africa CDC are Observers of the Board. A Secretariat operates under the umbrella of DZIF, the German Centre for Infection Research, and is funded by the German Ministry of Research, Technology and Space (BMFTR). Members: Australia* Gates Foundation Brazil Canada* China* European Commission (EC)* France* Germany* India* Italy* Japan* The Netherlands Norway Russia* South Africa Spain Sweden Switzerland Turkey* United Kingdom* United States of America* Wellcome * G20 members https://globalamrhub.org/board-of-members/
Commissioner Meetings
No recorded meetings with EU commissioners.